ArticlePediatric research2026
A-Maze-Ox: a novel gas-exchange-area-adjustable oxygenator for extremely preterm infants-design and proof of concept.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEach year, over half a million children worldwide are born extremely prematurely (EPI), often requiring potentially harmful ventilatory support. An artificial placenta with gas exchange provided by an oxygenator offers an alternative. However, current oxygenators are not designed for long-term applications in patients experiencing growth. Thus, a new type of "growing" oxygenator is needed.
methodsWe developed the A-Maze-Ox, a novel maze-inspired membrane oxygenator featuring two concentric compartments that can be opened sequentially to address patient growth. Each compartment has a priming volume of 5 mL and a gas exchange area of 0.065 m². The prototype was tested for feasibility, gas transfer performance and pressure loss according to ISO 7199.
resultsAdding the second compartment increased O
conclusionsThe A-Maze-Ox demonstrates the ability to adapt to increasing demands with good results in CO IMPACT: Current oxygenators cannot adapt to the dynamic patient growth of extremely premature infants. A-Maze-Ox-a novel membrane oxygenator with two compartments can adapt to growth. Each compartment has a volume of 5 mL and a gas exchange area of 0.065 m². Oxygen transfer increased by 57.06% and carbon dioxide transfer by 35.59% when adding the second compartment. A-Maze-Ox could improve health of extremely premature infants in the future.
Indexed as
Identifiers
41547963What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.